Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels

Endocrinology

Volumn 153, Issue 3, 2012, Pages 1269-1278

  Rossier, Michel F ^a,b   Pagano, Sabrina ^a   Python, Magaly ^a   Maturana, Andres D ^c   James, Richard W ^a   Mach, Franco̧is ^a,c   Roux Lombard, Pascale ^a   Vuilleumier, Nicolas ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Service of Clinical Chemistry and Toxicology   (Switzerland)

^c NAGAOKA UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTIBODY; APOLIPOPROTEIN A 1 ANTIBODY; CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DACTINOMYCIN; EPLERENONE; IMMUNOGLOBULIN G; MINERALOCORTICOID RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHRONOTROPISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART VENTRICLE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALDOSTERONE; ANIMALS; ANIMALS, NEWBORN; APOLIPOPROTEIN A-I; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; DACTINOMYCIN; ELECTROPHYSIOLOGY; IMMUNOGLOBULIN G; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; OXYGEN; PHOSPHATIDYLINOSITOL 3-KINASES; RATS; RATS, WISTAR; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE; TIME FACTORS;

EID: 84857422785     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1835     Document Type: Article

References (33)

1. Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P 2010 Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction. Eur Heart J 31:815-823
2. Vuilleumier N, Bas S, Pagano S, Montecucco F, Guerne PA, Finckh A, Lovis C, Mach F, Hochstrasser D, Roux-Lombard P, Gabay C 2010 Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 62:2640-2650
3. Kannel WB, Kannel C, Paffenbarger Jr RS, Cupples LA 1987 Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113:1489-1494 (Pubitemid 17092823)
4. Funder JW 2006 Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects. Endocrinology 147:5564-5567 (Pubitemid 44833472)
5. Funder JW 2005 The nongenomic actions of aldosterone. Endocr Rev 26:313-321 (Pubitemid 40686645)
6. Carey RM 2010 Aldosterone and cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 17:194-198
7. Gilbert KC, Brown NJ 2010 Aldosterone and inflammation. Curr Opin Endocrinol Diabetes Obes 17:199-204
8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Paliensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure.NEngl J Med 341:709-717 (Pubitemid 29407370)
9. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321 (Pubitemid 36384098)
10. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH 2003 Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108:1831-1838 (Pubitemid 37296092)
11. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B 2011 Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11-21
12. Lalevée N, Rebsamen MC, Barrère-Lemaire S, Perrier E, Nargeot J, Bénitah JP, Rossier MF 2005 Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc Res 67:216-224 (Pubitemid 40943614)
13. Rossier MF, Python M, Maturana AD 2010 Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes. Endocrinology 151:2777-2787
14. Muto T, Ueda N, Opthof T, Ohkusa T, Nagata K, Suzuki S, Tsuji Y, Horiba M, Lee JK, Honjo H, Kamiya K, Kodama I, Yasui K 2007 Aldosterone modulates I(f) current through gene expression in cultured neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol 293:H2710-H2718 (Pubitemid 350106494)
15. Vassort G, Talavera K, Alvarez JL 2006 Role of T-type Ca2+ channels in the heart. Cell Calcium 40:205-220 (Pubitemid 43942302)
16. Hoppe UC, Jansen E, Südkamp M, Beuckelmann DJ 1998 Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 97:55-65 (Pubitemid 28036155)
17. Liu SL, Schmuck S, Chorazcyzewski JZ, Gros R, Feldman RD 2003 Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation 108:2400-2406 (Pubitemid 37413549)
18. Rossier MF, Lenglet S, Vetterli L, Python M, Maturana A 2008 Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes. Hypertension 52:721-728
19. Funder JW 2004 Is aldosterone bad for the heart? Trends Endocrinol Metab 15:139-142 (Pubitemid 38510491)
20. Maturana A, Lenglet S, Python M, Kuroda S, Rossier MF 2009 Role of the T-type calcium channel CaV3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes. Endocrinology 150:3726-3734
21. Funder JW 2009 Reconsidering the roles of the mineralocorticoid receptor. Hypertension 53:286-290
22. Sato A, Funder JW 1996 High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology 137:4145-4153 (Pubitemid 26321859)
23. Young MJ, Morgan J, Brolin K, Fuller PJ, Funder JW 2010 2010 Activation of mineralocorticoid receptors by exogenous glucocorticoids and the development of cardiovascular inflammatory responses in adrenalectomized rats. Endocrinology 151:2622-2628
24. Mihailidou AS, Loan Le TY, Mardini M, Funder JW 2009 Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54:1306-1312
25. Vuilleumier N, Bratt J, Alizadeh R, Jogestrand T, Hafström I, Frostegård J 2010 AntiapoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity. Scand J Rheumatol 39:447-453
26. Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P 2008 Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome. Clin Sci (Lond) 115:25-33 (Pubitemid 351930790)
27. Struthers A, Krum H, Williams GH 2008 A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clin Cardiol 31:153-158 (Pubitemid 351556480)
28. Hescheler J, Schultz G 1994 Heterotrimeric G proteins involved in the modulation of voltage-dependent calcium channels of neuroendocrine cells. Ann NY Acad Sci 733:306-312
29. Li J, McMurray RW 2009 Effects of chronic exposure to DDT and TCDD on disease activity in murine systemic lupus erythematosus. Lupus 18:941-949
30. Schoenroth L, Chan S, Fritzler M 2004 Autoantibodies and levels of polychlorinated biphenyls in persons living near a hazardous waste treatment facility. J Investig Med 52:170-176 (Pubitemid 38856419)
31. Yurino H, Ishikawa S, Sato T, Akadegawa K, Ito T, Ueha S, Inadera H, Matsushima K 2004 Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicol Sci 81:139-147 (Pubitemid 39199872)
32. Curran J, Brown KH, Santiago DJ, Pogwizd S, Bers DM, Shannon TR 2010 Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca(2+)-calmodulin-dependent protein kinase II. J Mol Cell Cardiol 49:25-32
33. Sipido KR 2006 Calcium overload, spontaneous calcium release, and ventricular arrhythmias. Heart Rhythm 3:977-979 (Pubitemid 44103496)